Generic Side Effects: Are Adverse Reactions More Likely Than Brand-Name Drugs?
Explore whether generic drugs cause more side effects than brand-name medications. Learn about bioequivalence, the nocebo effect, and when to stick with brands.
Why Generic Drugs Affect People Differently: Bioequivalence, NTI Medications, and Real-World Risks
Explore why generic drugs affect individuals differently. Learn about bioequivalence limits, the impact of inactive ingredients, and risks for Narrow Therapeutic Index medications.
Sustaining Health After Switching to Generics: A Long-Term Guide
Learn how to maintain long-term health when switching from brand-name to generic medications, including risks of bioequivalence and strategies for NTI drugs.
International Perspectives on NTI Generics: Regulatory Approaches Compared
NTI generics like warfarin and levothyroxine require strict global regulation due to their narrow safety margin. This article compares FDA, EMA, and other international approaches to ensure patient safety and therapeutic consistency.
Prior Authorization for NTI Drugs: When Insurers Require Brand-Name Medications
NTI drugs like levothyroxine and phenytoin require extreme consistency-yet insurers often force patients through prior authorization to get brand-name versions. Here's why that's dangerous, how policies vary, and what you can do.